When used with traditional x-ray mammograms, sonographers say breast ultrasound can be an effective way for clinicians to cross-check images of cysts, calcifications, and other suspicious growths.To spur interest in ultrasound breast imaging, leading
When used with traditional x-ray mammograms, sonographers say breast ultrasound can be an effective way for clinicians to cross-check images of cysts, calcifications, and other suspicious growths.
To spur interest in ultrasound breast imaging, leading physicians and sonographers met this year to develop the first breast ultrasound certification exam. The exam will be offered by the American Registry of Diagnostic Medical Sonographers.
Breast ultrasound has been used extensively in Europe and Japan, but has been slow to catch on in the U.S.
Cynthia Rapp, a sonographic practitioner and chair of the ARDMS breast task force, led a classroom session at the American Institute of Ultrasound in Medicines annual convention in San Francisco this month on breast sonography.
Ultrasounds may be able to determine the amount of water density in the breast more accurately than the traditional x-ray mammogram.
Anytime there is the presence of water density, that is when (sonographers) may order an ultrasound, said Rapp.
Rapp said ultrasound works most effectively with a 10-MHz probe and harmonic tissue imaging.
Unfortunately, these features are more commonly found on high-end machines, she said.
If you can afford a $300,000 machine for breast imaging, that is fabulous. But most breast centers are purchasing medium-range machines, she said.
Ultrasound can identify ruptures in silicone breast implants and systems with color Doppler can be used to image cysts effectively, Rapp said. However, breast ultrasounds can produce artificial shadows that may confuse sonographers.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.